Cite
Rabbolini DJ, Gardiner EE, Morel-Kopp MC, et al. Anti-glycoprotein VI mediated immune thrombocytopenia: An under-recognized and significant entity?. Res Pract Thromb Haemost. 2017;1(2):291-295doi: 10.1002/rth2.12033.
Rabbolini, D. J., Gardiner, E. E., Morel-Kopp, M. C., Dunkley, S., Jahangiri, A., Lee, C. S., Stevenson, W. S., & Ward, C. M. (2017). Anti-glycoprotein VI mediated immune thrombocytopenia: An under-recognized and significant entity?. Research and practice in thrombosis and haemostasis, 1(2), 291-295. https://doi.org/10.1002/rth2.12033
Rabbolini, David J, et al. "Anti-glycoprotein VI mediated immune thrombocytopenia: An under-recognized and significant entity?." Research and practice in thrombosis and haemostasis vol. 1,2 (2017): 291-295. doi: https://doi.org/10.1002/rth2.12033
Rabbolini DJ, Gardiner EE, Morel-Kopp MC, Dunkley S, Jahangiri A, Lee CS, Stevenson WS, Ward CM. Anti-glycoprotein VI mediated immune thrombocytopenia: An under-recognized and significant entity?. Res Pract Thromb Haemost. 2017 Aug 24;1(2):291-295. doi: 10.1002/rth2.12033. eCollection 2017 Oct. PMID: 30046699; PMCID: PMC6058269.
Copy
Download .nbib